US 11,883,576 B2
Peritoneal dialysis intracycle osmotic agent adjustment
Martin T. Gerber, Maple Grove, MN (US); and Christopher M. Hobot, Rogers, MN (US)
Assigned to Mozarc Medical US LLC, Minneapolis, MN (US)
Filed by Medtronic, Inc., Minneapolis, MN (US)
Filed on Sep. 17, 2020, as Appl. No. 17/024,039.
Application 17/024,039 is a continuation of application No. 15/666,631, filed on Aug. 2, 2017, granted, now 10,874,790.
Claims priority of provisional application 62/373,228, filed on Aug. 10, 2016.
Prior Publication US 2021/0001031 A1, Jan. 7, 2021
Int. Cl. A61M 1/28 (2006.01); A61K 31/7004 (2006.01); A61K 31/718 (2006.01); A61M 1/16 (2006.01)
CPC A61M 1/282 (2014.02) [A61K 31/7004 (2013.01); A61K 31/718 (2013.01); A61M 1/1656 (2013.01); A61M 2202/0486 (2013.01); A61M 2205/3344 (2013.01); A61M 2205/50 (2013.01); A61M 2230/30 (2013.01)] 18 Claims
OG exemplary drawing
 
1. A method, comprising the steps of:
adjusting an osmotic agent concentration of peritoneal dialysate in the peritoneal cavity of a patient during a cycle by infusing a concentrated osmotic agent solution or by infusing sterile fluid into the peritoneal cavity of the patient by infusing the peritoneal dialysate into the peritoneal cavity of the patient at a beginning of the cycle and adjusting the osmotic agent concentration by selectively flowing fluid from an osmotic agent source or a sterile fluid source into the peritoneal cavity of the patient at a set time after infusing the peritoneal dialysate into the peritoneal cavity of the patient.